Abstract
<jats:p>Epilepsy, characterised by recurrent seizures, is one of the most common serious neurological conditions of childhood, estimated to affect 600,000 individuals in the United Kingdom. The management of drug‐resistant epilepsy is complex, often requiring multiple treatment approaches, which may include surgery, vagus nerve stimulation and ketogenic diet (KD) therapy as adjuvant therapies alongside ASM treatment. There are five types of KD used to treat drug‐resistant epilepsy today: classical KD, medium chain triglyceride KD, modified Atkins diet, modified ketogenic diet and low glycaemic index treatment, all with varying degrees of dietary restriction. KD therapy is a resource‐intensive treatment for the MDT, and, as such, average caseloads will often be lower than other areas of dietetics. The dietitian monitors the patient regularly, as often as daily during the first few weeks after commencing KD, and fine‐tunes the diet as needed to maximise the likelihood of success.</jats:p>